SYBX — SYNLOGIC, INC.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1527599 ·
Last close
$1.18
Market Cap
$14.45M
52W High
$1.30
52W Low
$0.60
ADV30
139,967
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -1,113,000 | 681,000 | 14,611,000 | 14,105,000 | 2,057,000 |
| Dec 2025 | 0 | — | -1,062,000 | 1,508,000 | 15,447,000 | 14,668,000 | 3,584,000 |
| Sep 2025 | 0 | — | -826,000 | -2,301,000 | 16,555,000 | 15,591,000 | 6,230,000 |
| Jun 2025 | 0 | — | -786,000 | -529,000 | 17,370,000 | 17,027,000 | 4,777,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-3,321,000
Investing CF
$155,000
Financing CF
$0
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.15
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-441,975,000
Inventory
—
Receivables
—
ST Investments
$0
EBIT TTM
$-3,787,000
Pretax Income TTM
$-641,000
Interest Exp TTM
$0
Analysts
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -3,532,000 | -1,005,000 | 15,447,000 | 3,584,000 | — | -4,359,000 |
| Dec 2024 | 8,000 | -15,777,000 | -23,359,000 | 19,826,000 | 7,075,000 | — | -31,658,000 |
| Dec 2023 | 3,371,000 | -55,161,000 | -61,273,000 | 75,550,000 | 42,779,000 | — | -51,614,000 |
| Dec 2022 | 1,180,000 | -67,419,000 | -66,147,000 | 110,865,000 | 28,255,000 | — | -56,888,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$101,000
NetIncome TTM
$-11,869,000
OpCashFlow TTM
$0
Assets (Latest)
$64,166,000
Forward EPS
$-0.47
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AKTX | Akari Therapeutics Plc | $14.54M | $7.47 | — |
| ADIL | ADIAL PHARMACEUTICALS, INC. | $14.18M | $5.40 | — |
| NRSN | NeuroSense Therapeutics Ltd. | $14.16M | $0.38 | — |
| GTBP | GT Biopharma, Inc. | $13.79M | $0.31 | — |
| PHIO | Phio Pharmaceuticals Corp. | $13.59M | $1.17 | — |
News headlines (Yahoo Finance, 1h cache)
Synlogic and Caldera sign merger agreement
2026-07-30 10:00 · Yahoo
Synlogic and Caldera Therapeutics Announce Merger and $278 Million Private Placement
2026-07-29 14:41 · Yahoo
Caldera, Vidya add to recent flurry of biotech mergers
2026-07-29 12:07 · Yahoo
Synlogic and Caldera Therapeutics Announce Merger Agreement and Concurrent Private Placement
2026-07-29 11:00 · Yahoo
We Think Synlogic (NASDAQ:SYBX) Can Afford To Drive Business Growth
2025-09-18 10:58 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.